"Letter from the Editor." Human Vaccines & Immunotherapeutics, 8(5), p. 541
Open access
99
Views
0
CrossRef citations to date
0
Altmetric
Editor's Corner
Letter from the Editor
Ronald W. Ellis Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, IsraelCorrespondence[email protected]
& Eva M. Riedmann Acquisitions Editor; Landes Bioscience; Vienna, Austria
Page 541
|
Published online: 01 May 2012
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.